サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1182111

副腎皮質ホルモンの世界市場規模調査＆予測：製品別、投与経路別、用途別、地域別分析、2022-2029年

Global Corticosteroids Market Size study & Forecast, by Product, Route of Administration, Application and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
副腎皮質ホルモンの世界市場規模調査＆予測：製品別、投与経路別、用途別、地域別分析、2022-2029年
出版日: 2022年11月16日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

副腎皮質で生成されるステロイドホルモンの一種で、腎臓病、自己免疫疾患、消化管疾患、皮膚疾患、脳浮腫など、さまざまな疾患の治療に使用されます。

また、これらのステロイドは、置換治療や臓器移植にも使用されています。副腎皮質ホルモン市場は、慢性疾患や感染症の増加、治療薬への応用の増加などの要因から拡大しています。医薬品分野における継続的な研究開発は、予測期間を通じて新たな市場の可能性を開くと予測されています。

国連が発表した2020年版レポートによると、現在72億人の人口が、2025年には82億人に増加すると予想されています。このため、2020年末までに慢性疾患の世界の負担は57%に増加すると予想されています。米国疾病対策予防センターの2020年版レポートによると、約2,500万人のアメリカ人が喘息を持っています。これはアメリカ人の約13人に1人に相当し、成人の8％、子どもの7％にあたります。喘息は、18歳以上の米国人2,000万人以上が罹患しています。しかし、長期使用中のコルチコステロイドに関連するリスク要因は、2022年から2029年の予測期間を通じて市場の成長を阻害します。

世界の副腎皮質ホルモン市場の調査のために考慮された主要な地域は、アジア太平洋、北米、欧州、ラテンアメリカ、および世界のその他の地域が含まれています。北米は、生活習慣病の発生率の増加や経済の発展、医療費の増加により、収益の面でスペースを支配していました。しかし、アジア太平洋地域は、技術的に高度な製品の高い採用により、最も急速に成長している地域であると予想されます。

本調査の目的は、近年におけるさまざまなセグメント＆国の市場規模を明らかにし、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むことを目的としています。

また、市場の将来的な成長を定義する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み入れています。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界・セグメント別市場推定・予測、2019-2029年
    • 副腎皮質ホルモン市場、地域別、2019-2029年
    • 副腎皮質ホルモン市場：製品別、2019年～2029年
    • 副腎皮質ホルモン市場：投与経路別、2019-2029年
    • 副腎皮質ホルモン市場：用途別、2019年-2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 副腎皮質ホルモンの世界市場定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 副腎皮質ホルモンの世界市場力学

  • 副腎皮質ホルモン市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 慢性疾患および感染症の有病率の増加
      • 治療用製品の用途の増加
    • 市場の課題
      • 副腎皮質ホルモンの長期使用に伴うリスク要因
    • 市場機会
      • 研究開発への投資の急増
      • 鼻と副鼻腔に関連する複雑性の急増

第4章 副腎皮質ホルモンの世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップ投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 副腎皮質ホルモンの世界市場：製品別

  • 市場スナップショット
  • 副腎皮質ホルモンの世界市場：製品別、業績-ポテンシャル分析
  • 副腎皮質ホルモンの世界市場、製品別推定・予測2019-2029年
  • 副腎皮質ホルモンの世界市場、サブセグメント分析
    • グルココルチコイド
    • ミネラルコルチコイド

第7章：副腎皮質ホルモンの世界市場：投与経路別

  • 市場スナップショット
  • 副腎皮質ホルモンの世界市場：投与経路別、性能-ポテンシャル分析
  • 副腎皮質ホルモンの世界市場、投与経路別推定・予測2019～2029年
  • 副腎皮質ホルモンの市場、サブセグメント分析
    • 局所用ステロイド剤
    • 吸入ステロイド剤
    • 経口剤
    • 全身投与用製剤
    • その他

第8章 副腎皮質ホルモンの世界市場：用途別

  • 市場スナップショット
  • 副腎皮質ホルモンの世界市場：用途別実績-ポテンシャル分析
  • 副腎皮質ホルモンの世界市場、用途別推定・予測2019-2029年
  • 副腎皮質ホルモンの市場、サブセグメント分析
    • リウマチの適応症
    • 皮膚アレルギー
    • 内分泌学
    • 消化器系疾患
    • 急性呼吸器疾患
    • その他

第9章 副腎皮質ホルモンの世界市場：地域別分析

  • 副腎皮質ホルモンの市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2019年～2029年
      • 投与経路別の推定・予測、2019年～2029年
      • アプリケーション別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の副腎皮質ホルモン市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域の副腎皮質ホルモン市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのコルチコステロイド市場のスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Johnson & Johnson Services, Inc.
      • 主要情報
      • 概要
      • 財務情報（データの入手状況により異なります）
      • 製品概要
      • 最近の動向
    • Pfizer Inc.
    • Sumitomo Corporation
    • GlaxoSmithKline plc
    • Novartis AG
    • Bayer AG Pharmaceutical
    • Sanofi S.A.
    • AstraZeneca plc
    • Merck & Co., Inc.,
    • Cipla Inc.

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Corticosteroids Market, report scope
  • TABLE 2. Global Corticosteroids Market estimates & forecasts by region 2019-2029 (USD Billion)
  • TABLE 3. Global Corticosteroids Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Corticosteroids Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
  • TABLE 5. Global Corticosteroids Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 6. Global Corticosteroids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Corticosteroids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Corticosteroids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Corticosteroids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Corticosteroids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Corticosteroids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Corticosteroids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Corticosteroids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Corticosteroids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Corticosteroids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Corticosteroids Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Corticosteroids Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Corticosteroids Market
  • TABLE 71. List of primary sources, used in the study of global Corticosteroids Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Corticosteroids Market, research methodology
  • FIG 2. Global Corticosteroids Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Corticosteroids Market, key trends 2021
  • FIG 5. Global Corticosteroids Market, growth prospects 2022-2029
  • FIG 6. Global Corticosteroids Market, porters 5 force model
  • FIG 7. Global Corticosteroids Market, pest analysis
  • FIG 8. Global Corticosteroids Market, value chain analysis
  • FIG 9. Global Corticosteroids Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Corticosteroids Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Corticosteroids Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Corticosteroids Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Corticosteroids Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Corticosteroids Market, regional snapshot 2019 & 2029
  • FIG 15. North America Corticosteroids Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Corticosteroids Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Corticosteroids Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Corticosteroids Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Corticosteroids Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Corticosteroids Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2029. Corticosteroids are a group of steroidal hormones that are generated in the adrenal cortex and are used to treat a variety of diseases, including kidney disease, autoimmune illness, GIT disease, skin disease, cerebral edema, and others. These steroids are also used in replacement treatment and organ transplantation. The Corticosteroids market is expanding because of factors such increase in the prevalence of chronic & infectious diseases and a rise in therapeutical product application. Continuing R&D in the pharmaceutical sector is predicted to open up new market possibilities throughout the forecast period.

According to the United Nations report 2020, the anticipated human population would rise from 7.2 billion now to 8.2 billion by 2025. By the end of 2020, this causes the worldwide burden of chronic illnesses to increase to 57%. About 25 million Americans have asthma, according to the Centers for Disease Control and Prevention's 2020 report. This equates to around 1 in 13 Americans, which includes 8% of adults and 7% of children. Asthma affects over 20 million American individuals who are 18 years of age and older. However, risk factors associated with Corticosteroids on Prolonged use stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Corticosteroids Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the increasing incidence of lifestyle-related diseases and developed economy, increasing health care expenditure. However, Asia Pacific is expected to be the fastest growing region due to the high adoption of technologically advanced products.

Major market players included in this report are:

Johnson & Johnson Services, Inc.

Pfizer Inc.

Sumitomo Corporation

GlaxoSmithKline plc

Novartis AG

Bayer AG Pharmaceutical

Sanofi S.A.

AstraZeneca plc

Merck & Co., Inc.

Cipla Inc.

Recent Developments in the Market:

  • The first participant in a pilot trial testing vamorolone as a possible therapy for Becker Muscular Dystrophy (BMD) received the first dosage in August 2022. As a potential treatment for various forms of muscular dystrophy, ReveraGen BioPharma has been researching and developing the steroid treatment.
  • In April 2022, Global pharmaceutical business Eli Lilly and Company announced that the third pivotal Phase 3 trial using Lebrikizumab, an IL-13 inhibitor, in combination with Tropical Corticosteroids (TCS), significantly reduced disease severity in patients with moderate-to-severe Atopic Dermatitis (AD) (ADhere).

Global Corticosteroids Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Route of Administration, Application, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Glucocorticoids

Mineralocorticoids

By Route of Administration:

Topical steroids

Inhaled steroids

Oral forms

Systemic forms

Others

By Application:

Rheumatology indications

Skin allergies

Endocrinology

Gastroenterology

Acute respiratory diseases

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Corticosteroids Market, by region, 2019-2029 (USD Billion)
    • 1.2.2. Corticosteroids Market, by Product, 2019-2029 (USD Billion)
    • 1.2.3. Corticosteroids Market, by Route of Administration, 2019-2029 (USD Billion)
    • 1.2.4. Corticosteroids Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Corticosteroids Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Corticosteroids Market Dynamics

  • 3.1. Corticosteroids Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in prevalence of chronic & infectious diseases
      • 3.1.1.2. Rise in therapeutical product application
    • 3.1.2. Market Challenges
      • 3.1.2.1. Risk factors associated with Corticosteroids on Prolonged use
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Surging investment in Research and Development
      • 3.1.3.2. Surging prevalence of complexities associated with the nose and sinus

Chapter 4. Global Corticosteroids Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Corticosteroids Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Corticosteroids Market by Product, Performance - Potential Analysis
  • 6.3. Global Corticosteroids Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Corticosteroids Market, Sub Segment Analysis
    • 6.4.1. Glucocorticoids
    • 6.4.2. Mineralocorticoids

Chapter 7. Global Corticosteroids Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Corticosteroids Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Corticosteroids Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
  • 7.4. Corticosteroids Market, Sub Segment Analysis
    • 7.4.1. Topical steroids
    • 7.4.2. Inhaled steroids
    • 7.4.3. Oral forms
    • 7.4.4. Systemic forms
    • 7.4.5. Others

Chapter 8. Global Corticosteroids Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Corticosteroids Market by Application, Performance - Potential Analysis
  • 8.3. Global Corticosteroids Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 8.4. Corticosteroids Market, Sub Segment Analysis
    • 8.4.1. Rheumatology indications
    • 8.4.2. Skin allergies
    • 8.4.3. Endocrinology
    • 8.4.4. Gastroenterology
    • 8.4.5. Acute respiratory diseases
    • 8.4.6. Others

Chapter 9. Global Corticosteroids Market, Regional Analysis

  • 9.1. Corticosteroids Market, Regional Market Snapshot
  • 9.2. North America Corticosteroids Market
    • 9.2.1. U.S. Corticosteroids Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Application breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Corticosteroids Market
  • 9.3. Europe Corticosteroids Market Snapshot
    • 9.3.1. U.K. Corticosteroids Market
    • 9.3.2. Germany Corticosteroids Market
    • 9.3.3. France Corticosteroids Market
    • 9.3.4. Spain Corticosteroids Market
    • 9.3.5. Italy Corticosteroids Market
    • 9.3.6. Rest of Europe Corticosteroids Market
  • 9.4. Asia-Pacific Corticosteroids Market Snapshot
    • 9.4.1. China Corticosteroids Market
    • 9.4.2. India Corticosteroids Market
    • 9.4.3. Japan Corticosteroids Market
    • 9.4.4. Australia Corticosteroids Market
    • 9.4.5. South Korea Corticosteroids Market
    • 9.4.6. Rest of Asia Pacific Corticosteroids Market
  • 9.5. Latin America Corticosteroids Market Snapshot
    • 9.5.1. Brazil Corticosteroids Market
    • 9.5.2. Mexico Corticosteroids Market
  • 9.6. Rest of The World Corticosteroids Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Johnson & Johnson Services, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Pfizer Inc.
    • 10.2.3. Sumitomo Corporation
    • 10.2.4. GlaxoSmithKline plc
    • 10.2.5. Novartis AG
    • 10.2.6. Bayer AG Pharmaceutical
    • 10.2.7. Sanofi S.A.
    • 10.2.8. AstraZeneca plc
    • 10.2.9. Merck & Co., Inc.,
    • 10.2.10. Cipla Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption